Hypoglycemia during hyperosmolar hyperglycemic crises is associated with long-term mortality.

Tomás González-VidalCarmen LambertAna Victoria GarcíaElsa Villa-FernándezPedro PujanteJessica Ares-BlancoEdelmiro Menéndez Torre Elías Delgado-Álvarez

Published in: Diabetology & metabolic syndrome (2024)

Hypoglycemia during hyperosmolar hyperglycemic crises is a marker of long-term mortality, especially when it occurs during the initial intravenous insulin therapy phase.

Keyphrases

type diabetes
glycemic control
cardiovascular events
risk factors
high dose
cardiovascular disease
coronary artery disease
insulin resistance
mesenchymal stem cells
low dose
adipose tissue
cell therapy